These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

356 related items for PubMed ID: 22740428

  • 1. Prevalence and clinical significance of anti-ribosomal P antibody in childhood-onset systemic lupus erythematosus.
    Aldar H, Lapa AT, Bellini B, Sinicato NA, Postal M, Fernandes PT, Costallat LT, Marini R, Appenzeller S.
    Lupus; 2012 Oct; 21(11):1225-31. PubMed ID: 22740428
    [Abstract] [Full Text] [Related]

  • 2. Prevalence of depressive and anxiety disorders in systemic lupus erythematosus and their association with anti-ribosomal P antibodies.
    Nery FG, Borba EF, Viana VS, Hatch JP, Soares JC, Bonfá E, Neto FL.
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Apr 01; 32(3):695-700. PubMed ID: 18077068
    [Abstract] [Full Text] [Related]

  • 3. Prevalence of autoantibodies to ribosomal P proteins in juvenile-onset systemic lupus erythematosus compared with the adult disease.
    Reichlin M, Broyles TF, Hubscher O, James J, Lehman TA, Palermo R, Stafford HA, Taylor-Albert E, Wolfson-Reichlin M.
    Arthritis Rheum; 1999 Jan 01; 42(1):69-75. PubMed ID: 9920016
    [Abstract] [Full Text] [Related]

  • 4. Th1/Th2 cytokine profile in childhood-onset systemic lupus erythematosus.
    Postal M, Peliçari KO, Sinicato NA, Marini R, Costallat LT, Appenzeller S.
    Cytokine; 2013 Mar 01; 61(3):785-91. PubMed ID: 23332615
    [Abstract] [Full Text] [Related]

  • 5. Lymphocytotoxic antibodies in systemic lupus erythematosus are associated with disease activity irrespective of the presence of neuropsychiatric manifestations.
    Magalhães MB, da Silva LM, Voltarelli JC, Donadi EA, Louzada-Junior P.
    Scand J Rheumatol; 2007 Mar 01; 36(6):442-7. PubMed ID: 18092265
    [Abstract] [Full Text] [Related]

  • 6. Anti-ribosomal P antibody: a multicenter study in childhood-onset systemic lupus erythematosus patients.
    Valões CC, Molinari BC, Pitta AC, Gormezano NW, Farhat SC, Kozu K, Sallum AM, Appenzeller S, Sakamoto AP, Terreri MT, Pereira RM, Magalhães CS, Ferreira JC, Barbosa CM, Gomes FH, Bonfá E, Silva CA, Brazilian Childhood-onset Systemic Lupus Erythematosus Group.
    Lupus; 2017 Apr 01; 26(5):484-489. PubMed ID: 28394238
    [Abstract] [Full Text] [Related]

  • 7. Difference in disease features between childhood-onset and adult-onset systemic lupus erythematosus.
    Brunner HI, Gladman DD, Ibañez D, Urowitz MD, Silverman ED.
    Arthritis Rheum; 2008 Feb 01; 58(2):556-62. PubMed ID: 18240232
    [Abstract] [Full Text] [Related]

  • 8. Common mental disorders and psychological distress in systemic lupus erythematosus are not associated with disease activity.
    Jarpa E, Babul M, Calderón J, González M, Martínez ME, Bravo-Zehnder M, Henríquez C, Jacobelli S, González A, Massardo L.
    Lupus; 2011 Jan 01; 20(1):58-66. PubMed ID: 21078764
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Greater accrual damage in late-onset systemic lupus erythematosus: a long-term follow-up study.
    Appenzeller S, Pereira DA, Costallat LT.
    Lupus; 2008 Nov 01; 17(11):1023-8. PubMed ID: 18852227
    [Abstract] [Full Text] [Related]

  • 11. Clinical and serologic factors associated with lupus pleuritis.
    Mittoo S, Gelber AC, Hitchon CA, Silverman ED, Pope JE, Fortin PR, Pineau C, Smith CD, Arbillaga H, Gladman DD, Urowitz MB, Zummer M, Clarke AE, Bernatsky S, Hudson M, Tucker LB, Petty RE, Canadian Network for Improved Outcomes in Systemic Lupus Erythematosus (CaNIOS), Peschken CA.
    J Rheumatol; 2010 Apr 01; 37(4):747-53. PubMed ID: 20110526
    [Abstract] [Full Text] [Related]

  • 12. Differences in Clinical Features and Mortality between Childhood-onset and Adult-onset Systemic Lupus Erythematosus: A Prospective Single-center Study.
    Joo YB, Park SY, Won S, Bae SC.
    J Rheumatol; 2016 Aug 01; 43(8):1490-7. PubMed ID: 27252431
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. S100β is associated with cognitive impairment in childhood-onset systemic lupus erythematosus patients.
    Lapa AT, Postal M, Sinicato NA, Bellini BS, Fernandes PT, Marini R, Appenzeller S.
    Lupus; 2017 Apr 01; 26(5):478-483. PubMed ID: 28394234
    [Abstract] [Full Text] [Related]

  • 16. Pentraxin-3 levels are associated with vasculitis and disease activity in childhood-onset systemic lupus erythematosus.
    Sahin S, Adrovic A, Barut K, Durmus S, Gelisgen R, Uzun H, Kasapcopur O.
    Lupus; 2017 Sep 01; 26(10):1089-1094. PubMed ID: 28420068
    [Abstract] [Full Text] [Related]

  • 17. A Multicenter Study of Invasive Fungal Infections in Patients with Childhood-onset Systemic Lupus Erythematosus.
    Silva MF, Ferriani MP, Terreri MT, Pereira RM, Magalhães CS, Bonfá E, Campos LM, Okuda EM, Appenzeller S, Ferriani VP, Barbosa CM, Ramos VC, Lotufo S, Silva CA.
    J Rheumatol; 2015 Dec 01; 42(12):2296-303. PubMed ID: 26568586
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Anti-nucleosome and anti-chromatin antibodies are present in active systemic lupus erythematosus but not in the cutaneous form of the disease.
    Souza A, da Silva LM, Oliveira FR, Roselino AM, Louzada-Junior P.
    Lupus; 2009 Mar 01; 18(3):223-9. PubMed ID: 19213860
    [Abstract] [Full Text] [Related]

  • 20. Anti-ribosomal-P antibodies in lupus patients and healthy controls: evaluation of three ELISA assays.
    Agmon-Levin N, Gilburd B, Kivity S, Katz BS, Flitman-Katzevman I, Shoenfeld N, Paran D, Langevitz P, Shoenfeld Y.
    Isr Med Assoc J; 2009 Jul 01; 11(7):403-6. PubMed ID: 19911490
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.